Select Page

Benzodiazepine Information Coalition

Educating about the potential adverse effects of

benzodiazepines taken as prescribed.

‘I just thought that it was such an impossible thing’: A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework

From Tom Lynch MPharm, Cristín Ryan PhD, Cathal A. Cadogan PhD published in Health Expectations Objective To explore barriers and facilitators to discontinuing BZRA use from the perspective of both current and previous long-term BZRA users. Design/Setting and...

Benzo Bulletin: Melanie Davis: REST, Benzodiazepines, & Withdrawal Support

Melanie Davis has more than 25 years of experience as the manager of REST (Recovery Experience Sleeping Pills &...

Corey Haim

American actor Corey Haim died in 2010 at age 38. Haim was known for his work in 1980’s films License to Drive and The Lost Boys. California Attorney General Edmund G. Brown, Jr. revealed in a press conference that the month leading up to his death, Haim illegally...

Pilot Trial of Gabapentin for the Treatment of Benzodiazepine Abuse or Dependence in Methadone Maintenance Patients

Abstract Background Benzodiazepine (BZD) use disorders are a common clinical problem among methadone maintenance treatment patients and have adverse effects on clinical outcomes. Objectives To evaluate gabapentin for the outpatient treatment of BZD abuse or dependence...

Benzo Bulletin: Colton Underwood tried to suppress homosexuality by ‘taking medication daily’

From Nicholas Hautman at Page Six: Colton Underwood admits he struggled with being gay so much so that he used to abuse...

Benzo Bulletin: Beneficial Valium Can Also Prove to be Bad Medicine

A New York Times article that ran in 1979: Last week a Senate panel held hearings into the prescribing of Valium, now taken...

What happens when patients know more than their doctors? Experiences of health interactions after diabetes patient education: a qualitative patient-led study

This study from Rosamund Snow, Charlotte Humphrey and Jane Sandall examines a situation many Benzo-harmed patients find themselves in — knowing more about the topic than their own doctors. Abstract Objective To explore the impact of patient education on the lives of...

New Video: Knowledge Gaps in Benzodiazepine Deprescribing with Dr. Sumit Agawal

Dr. Sumit Agawal, an internal medicine physician and instructor at Harvard Medical School, spoke at Duke Margolis Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives in July, 2021.  In this clip, he describes his own unhelpful experience...

Aurelio Costarella

Australian Designer Aurelio Costarella was prescribed benzodiazepines by his doctor for anxiety. Aurelio, in an ABC interview, recalls his doctor’s advice and prescribing: I went from one benzo to two benzos, to three benzos and you know, twice daily, three times...

Benzo Bulletin: Christy Moore: ‘The Valium came about because my poor mother introduced me to it’

From Independent Ireland's Donal Lynch: The wreckage from his past began to catch up with him, however. He has been open...

Media Outreach

As an integral part of our outreach efforts, we offer awareness and education via many well-known media outlets and publications. 

Professional Speaking

We offer awareness and education through public speaking about benzodiazepine issues both in public and professional settings.

Research and Publications

Through our research we contribute to the scientific discussion about benzodiazepines.

Conferences and Events

Our participation in conferences and other events brings the benzodiazepine-harm message to the public.

Our Mission

Educating about the potential adverse effects of benzodiazepines taken as prescribed.


Who We Are

We are a group of patients and medical professionals who believe the over-prescription of benzodiazepines without proper warning has resulted in a growing national epidemic of benzodiazepine injury.


Our Vision

We seek to break the stigma and raise awareness around prescribed benzodiazepine injury, provide a voice to the patients who are suffering, and facilitate research and access to competent, evidence-based medical care for those impacted by benzodiazepine induced disability.


Why We Are Different

With both professional and patient experience, we exist solely to raise awareness of the complex issues surrounding prescribed benzodiazepine use, and to prevent further patient injury.


Our History

In the summer of 2016, Benzodiazepine Information Coalition formed as a U.S. non-profit organization dedicated to advocating for awareness and reform around the dangers of benzodiazepines, motivated by the years of watching benzodiazepine-injury support groups grow in membership by the thousands without any corresponding increase in attention from the public or medical community.


Our Strategy

We seek change by educating and partnering with doctors, mental health providers, journalists, lawmakers, researchers, the benzodiazepine-impacted community, and society at large.


Our Philosophy

Our work will continue until benzodiazepines are at the forefront of the national healthcare conversation; until patients are given adequate informed consent; until the rate of injury is significantly lowered; and until those cases that remain are understood and treated appropriately.

Media Outreach

Some of the media outlets we have assisted…